Copyright
©The Author(s) 2017.
World J Gastroenterol. Nov 14, 2017; 23(42): 7541-7550
Published online Nov 14, 2017. doi: 10.3748/wjg.v23.i42.7541
Published online Nov 14, 2017. doi: 10.3748/wjg.v23.i42.7541
Figure 2 Heat shock protein 110 suppression by KNK437 under hyperthermic conditions.
HSP110 expression in MKN45 cells was suppressed by KNK437 under hyperthermic conditions of 43 °C. A: Western blots of HSP110 and β-actin expression; B: Relative expression of HSP110 (normalized to β-actin). C: Schematic representation of experimental timeline. HSP110: Heat shock protein 110; HT: Heat treatment.
- Citation: Kimura A, Ogata K, Altan B, Yokobori T, Mochiki E, Yanai M, Kogure N, Yanoma T, Suzuki M, Bai T, Kuwano H. Nuclear heat shock protein 110 expression is associated with poor prognosis and hyperthermo-chemotherapy resistance in gastric cancer patients with peritoneal metastasis. World J Gastroenterol 2017; 23(42): 7541-7550
- URL: https://www.wjgnet.com/1007-9327/full/v23/i42/7541.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i42.7541